GlassScriptPhysician profile
Jaskern Dhami
NPI 1225680259
$10,290.78
in general payments reported to CMS, 2019-2025
23 companies · $813 in 2025
The $813 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,947 · 2023: $4,891 · 2024: $1,640 · 2025: $813.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,510 · Travel and Lodging: $1,834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,509.95 |
| Travel and Lodging | $1,834.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,219.51 | 2022-2025 | Prostep, Augment Injectable, Prostep Mica |
| Medinc of Texas | $1,213.34 | 2022 | |
| Imbed Biosciences INC. | $1,093.95 | 2023 | |
| Smith+Nephew, INC. | $819.87 | 2022-2024 | Evos, Hat-Trick, Bone Anchors With Arthroscopic Delivery System |
| Treace Medical Concepts, INC. | $759.25 | 2023-2024 | |
| Paragon 28, INC. | $427.82 | 2023 | Portfolio, Activcore Nail |
| Integra Lifesciences Corporation | $358.83 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bone Support INC. | $254.51 | 2024 | Cerament G, Ceramentbone Void Filler |
| Fusion Orthopedics USA, LLC | $233.28 | 2023-2025 | |
| Pylant Medical | $164.84 | 2023-2024 | |
| Polynovo North America LLC | $128.66 | 2025 | Novosorb Btm |
| Horizon Therapeutics Plc | $124.99 | 2023 | Krystexxa |
| Vertex Pharmaceuticals Incorporated | $124.91 | 2025 | |
| Medical Device Business Services, INC. | $100.00 | 2023 | |
| Mimedx Group, INC. | $61.42 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $39.34 | 2023 | Motoband |
| Ibsa Pharma INC. | $37.01 | 2023-2025 | Tirosint, Flector, Tirosint |
| Averitas Pharma INC. | $29.67 | 2024 | Qutenza |
| Orthofix Medical, INC. | $27.93 | 2025 | Truelok |
| Kerecis Limited | $21.54 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Paratek Pharmaceuticals, INC. | $17.59 | 2023 | Nuzyra |
| Kowa Pharmaceuticals America, INC. | $17.22 | 2023 | Seglentis |
| Nevro Corp. | $15.30 | 2023 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaskern Dhami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.